1 Study Coverage

• 1.1 Tofacitinib Product Introduction
• 1.2 Market Segments
• 1.3 Key Tofacitinib Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Tofacitinib Market Size Growth Rate by Type
  • 1.4.2 5mg*60 Tablets
  • 1.4.3 5mg*10 Tablets
  • 1.4.4 10mg*10 Tablets
  • 1.4.5 5mg*30 Tablets
  • 1.4.6 5mg*14 Tablets
  • 1.4.7 10mg*14 Tablets
• 1.5 Market by Application
  • 1.5.1 Global Tofacitinib Market Size Growth Rate by Application
  • 1.5.2 Rheumatoid Arthritis
  • 1.5.3 Ulcerative Colitis
  • 1.5.4 Psoriasis
  • 1.5.5 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Tofacitinib Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Tofacitinib Industry
    • 1.6.1.1 Tofacitinib Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Tofacitinib Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Tofacitinib Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Tofacitinib Market Size Estimates and Forecasts
  • 2.1.1 Global Tofacitinib Revenue 2015-2026
  • 2.1.2 Global Tofacitinib Sales 2015-2026
• 2.2 Tofacitinib Market Size by Region: 2020 Versus 2026
  • 2.2.1 Global Tofacitinib Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Tofacitinib Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Tofacitinib Competitor Landscape by Players

• 3.1 Tofacitinib Sales by Manufacturers
  • 3.1.1 Tofacitinib Sales by Manufacturers (2015-2020)
  • 3.1.2 Tofacitinib Sales Market Share by Manufacturers (2015-2020)
• 3.2 Tofacitinib Revenue by Manufacturers
  • 3.2.1 Tofacitinib Revenue by Manufacturers (2015-2020)
  • 3.2.2 Tofacitinib Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Tofacitinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Tofacitinib Revenue in 2019
  • 3.2.5 Global Tofacitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Tofacitinib Price by Manufacturers
• 3.4 Tofacitinib Manufacturing Base Distribution, Product Types
  • 3.4.1 Tofacitinib Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Tofacitinib Product Type
  • 3.4.3 Date of International Manufacturers Enter into Tofacitinib Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Tofacitinib Market Size by Type (2015-2020)
  • 4.1.1 Global Tofacitinib Sales by Type (2015-2020)
  • 4.1.2 Global Tofacitinib Revenue by Type (2015-2020)
  • 4.1.3 Tofacitinib Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Tofacitinib Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Tofacitinib Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Tofacitinib Revenue Forecast by Type (2021-2026)
  • 4.2.3 Tofacitinib Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Tofacitinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

• 5.1 Global Tofacitinib Market Size by Application (2015-2020)
  • 5.1.1 Global Tofacitinib Sales by Application (2015-2020)
  • 5.1.2 Global Tofacitinib Revenue by Application (2015-2020)
  • 5.1.3 Tofacitinib Price by Application (2015-2020)
• 5.2 Tofacitinib Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Tofacitinib Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Tofacitinib Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Tofacitinib Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Tofacitinib by Country
  • 6.1.1 North America Tofacitinib Sales by Country
  • 6.1.2 North America Tofacitinib Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Tofacitinib Market Facts & Figures by Type
• 6.3 North America Tofacitinib Market Facts & Figures by Application

7 Europe

• 7.1 Europe Tofacitinib by Country
  • 7.1.1 Europe Tofacitinib Sales by Country
  • 7.1.2 Europe Tofacitinib Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Tofacitinib Market Facts & Figures by Type
• 7.3 Europe Tofacitinib Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Tofacitinib by Region
  • 8.1.1 Asia Pacific Tofacitinib Sales by Region
  • 8.1.2 Asia Pacific Tofacitinib Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Tofacitinib Market Facts & Figures by Type
• 8.3 Asia Pacific Tofacitinib Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Tofacitinib by Country
  • 9.1.1 Latin America Tofacitinib Sales by Country
  • 9.1.2 Latin America Tofacitinib Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Tofacitinib Market Facts & Figures by Type
• 9.3 Central & South America Tofacitinib Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Tofacitinib by Country
  • 10.1.1 Middle East and Africa Tofacitinib Sales by Country
  • 10.1.2 Middle East and Africa Tofacitinib Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Tofacitinib Market Facts & Figures by Type
• 10.3 Middle East and Africa Tofacitinib Market Facts & Figures by Application

11 Company Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Corporation Information
  • 11.1.2 Pfizer Description, Business Overview and Total Revenue
  • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Pfizer Tofacitinib Products Offered
  • 11.1.5 Pfizer Recent Development
• 11.2 Globe Pharmaceuticals
  • 11.2.1 Globe Pharmaceuticals Corporation Information
  • 11.2.2 Globe Pharmaceuticals Description, Business Overview and Total Revenue
  • 11.2.3 Globe Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Globe Pharmaceuticals Tofacitinib Products Offered
  • 11.2.5 Globe Pharmaceuticals Recent Development
• 11.3 Delta Pharma Limited
  • 11.3.1 Delta Pharma Limited Corporation Information
  • 11.3.2 Delta Pharma Limited Description, Business Overview and Total Revenue
  • 11.3.3 Delta Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Delta Pharma Limited Tofacitinib Products Offered
  • 11.3.5 Delta Pharma Limited Recent Development
• 11.4 Beacon Pharmaceuticals
  • 11.4.1 Beacon Pharmaceuticals Corporation Information
  • 11.4.2 Beacon Pharmaceuticals Description, Business Overview and Total Revenue
  • 11.4.3 Beacon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Beacon Pharmaceuticals Tofacitinib Products Offered
  • 11.4.5 Beacon Pharmaceuticals Recent Development
• 11.5 Drug International
  • 11.5.1 Drug International Corporation Information
  • 11.5.2 Drug International Description, Business Overview and Total Revenue
  • 11.5.3 Drug International Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Drug International Tofacitinib Products Offered
  • 11.5.5 Drug International Recent Development
• 11.1 Pfizer
  • 11.1.1 Pfizer Corporation Information
  • 11.1.2 Pfizer Description, Business Overview and Total Revenue
  • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Pfizer Tofacitinib Products Offered
  • 11.1.5 Pfizer Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Tofacitinib Market Estimates and Projections by Region
  • 12.1.1 Global Tofacitinib Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Tofacitinib Revenue Forecast by Regions 2021-2026
• 12.2 North America Tofacitinib Market Size Forecast (2021-2026)
  • 12.2.1 North America: Tofacitinib Sales Forecast (2021-2026)
  • 12.2.2 North America: Tofacitinib Revenue Forecast (2021-2026)
  • 12.2.3 North America: Tofacitinib Market Size Forecast by Country (2021-2026)
• 12.3 Europe Tofacitinib Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Tofacitinib Sales Forecast (2021-2026)
  • 12.3.2 Europe: Tofacitinib Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Tofacitinib Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Tofacitinib Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Tofacitinib Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Tofacitinib Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Tofacitinib Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Tofacitinib Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Tofacitinib Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Tofacitinib Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Tofacitinib Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Tofacitinib Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Tofacitinib Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Tofacitinib Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Tofacitinib Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Tofacitinib Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Tofacitinib Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source

Tofacitinib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tofacitinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Tofacitinib market is segmented into
5mg*60 Tablets
5mg*10 Tablets
10mg*10 Tablets
5mg*30 Tablets
5mg*14 Tablets
10mg*14 Tablets

Segment by Application, the Tofacitinib market is segmented into
Rheumatoid Arthritis
Ulcerative Colitis
Psoriasis
Other

Regional and Country-level Analysis
The Tofacitinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tofacitinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tofacitinib Market Share Analysis
Tofacitinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tofacitinib business, the date to enter into the Tofacitinib market, Tofacitinib product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Globe Pharmaceuticals
Delta Pharma Limited
Beacon Pharmaceuticals
Drug International
...